Skip to main content
Clinical Trials/DRKS00023277
DRKS00023277
Completed
Not Applicable

Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-PROGRESS) - PROVID-PROGRESS

Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation0 sites94 target enrollmentNovember 9, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
U07.1
Sponsor
Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation
Enrollment
94
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Charité – Universitätsmedizin Berlin, Med. Klinik m. S. Infektiologie und Pneumologie, und Arbeitsbereich Pulmonale Inflammation

Eligibility Criteria

Inclusion Criteria

  • Positive detection of SARS\-CoV\-2\-virus, Informed consent signed

Exclusion Criteria

  • Patient participation in PROVID\-CAPNETZ, PROVID\-PROGRESS or PROVID\-CAPSyS at an earlier time, simultaneous participation in PROVID\-CAPNETZ, pregnancy, breast feeding period, active tuberculosis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecified
DRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400
Recruiting
Not Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosis
DRKS00031139MPI-NAT1,000
Recruiting
Not Applicable
Testing novel biomarkers for the diagnosis of the delayed sleep wake phase disorder (DSWPD) in young adultsG47Sleep disorders
DRKS00030981Charitè Universitätmedizin (Chronobiology Lab)32
Recruiting
Not Applicable
Discovery of Novel Biomarkers for the Diagnosis of TB DiseaseA15Respiratory tuberculosis, bacteriologically and histologically confirmed
DRKS00032445Roche360
Not yet recruiting
Not Applicable
Identification of biomarkers and pathogenesis of lung cancer without targeted metabolomics based on uplc-q-tof /MSung cancer
ITMCTR1900002555The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine